Sentinel Lymph Node Biopsy Imaging Agents Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Radioactive Tracers, Dye-Based Agents), By Application (Breast Cancer, Melanoma), By Procedure, By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product
                        1.1.2. Application
                        1.1.3. Procedure
                        1.1.4. End Use
                        1.1.5. Regional scope
                        1.1.6. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Sentinel Lymph Node Biopsy Imaging Agents Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising global cancer incidence
                            3.2.1.2. Shift toward minimally invasive procedures
                            3.2.1.3. Technological advancements in tracers
                        3.2.2. Market restraint analysis
                            3.2.2.1. Skilled labor shortage
                            3.2.2.2. High capital & procedure costs
                        3.2.3. Market opportunity analysis
                            3.2.3.1. Expansion of non-radioactive alternatives
                            3.2.3.2. Integration of theranostics and hybrid agents
                            3.2.3.3. Expansion into new clinical applications
                            3.2.3.4. Increasing AI and robot-assisted surgery
                            3.2.3.5. Growing number of cinical trials
                            3.2.3.6. Growth in outpatient adoption
                        3.2.4. Market challenge analysis
                            3.2.4.1. Lack of standardization
                            3.2.4.2. Logistical & regulatory hurdles
                            3.2.4.3. Competition from alternative techniques
                    3.3. Sentinel Lymph Node Biopsy Imaging Agents Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological landscape
Chapter 4. Sentinel Lymph Node Biopsy Imaging Agents Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Product Movement Analysis
                    4.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
                    4.4. Radioactive Tracers
                        4.4.1. Radioactive tracers market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.4.1.1. Technetium-99m Sulfur Colloid
                                4.4.1.1.1. Technetium-99m sulfur colloid market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.4.1.2. Technetium-99m nanocolloid
                                4.4.1.2.1. Technetium-99m nanocolloid market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.4.1.3. Tilmanocept (Lymphoseek)
                                4.4.1.3.1. Tilmanocept (Lymphoseek) market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.4.1.4. Others
                                4.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
                    4.5. Dye-Based Agents
                        4.5.1. Dye-based agents market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.5.1.1. Isosulfan Blue
                                4.5.1.1.1. Isosulfan Blue market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.5.1.2. Patent Blue V
                                4.5.1.2.1. Patent Blue V market estimates and forecasts for 2021 to 2033 (USD Million)
                            4.5.1.3. Methylene Blue
                                4.5.1.3.1. Methylene Blue market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Sentinel Lymph Node Biopsy Imaging Agents Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Application Movement Analysis
                    5.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Breast Cancer
                        5.4.1. Breast cancer market estimates and forecast 2021 to 2033 (USD Million)
                    5.5. Melanoma
                        5.5.1. Melanoma market estimates and forecast 2021 to 2033 (USD Million)
                    5.6. Head & Neck Cancer
                        5.6.1. Head & neck cancer market estimates and forecast 2021 to 2033 (USD Million)
                    5.7. Gynecological Cancers
                        5.7.1. Gynecological cancers market estimates and forecast 2021 to 2033 (USD Million)
                    5.8. Other Indications
                        5.8.1. Other indications market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. Sentinel Lymph Node Biopsy Imaging Agents Market: Procedure Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Procedure Movement Analysis
                    6.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
                    6.4. Open Surgery
                        6.4.1. Open surgery market estimates and forecast 2021 to 2033 (USD Million)
                    6.5. Minimally Invasive Surgery
                        6.5.1. Minimally invasive surgery market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Sentinel Lymph Node Biopsy Imaging Agents Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market End Use Movement Analysis
                    7.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    7.4. Hospitals
                        7.4.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
                    7.5. Sinus Lift
                        7.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
                    7.6. Ambulatory Surgical Centers
                        7.6.1. Ambulatory surgical centers market estimates and forecast 2021 to 2033 (USD Million)
                    7.7. Cancer Specialty Clinics
                        7.7.1. Cancer specialty clinics market estimates and forecast 2021 to 2033 (USD Million)
Chapter 8. Sentinel Lymph Node Biopsy Imaging Agents Market: Regional Estimates & Trend Analysis By Product, By Procedure, By End Use and By Application
                    8.1. Regional Dashboard
                    8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
                    8.3. North America
                        8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
                        8.3.2. U.S.
                            8.3.2.1. Key country dynamics
                            8.3.2.2. Competitive scenario
                            8.3.2.3. Regulatory framework
                            8.3.2.4. Reimbursement scenario
                            8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
                        8.3.3. Canada
                            8.3.3.1. Key country dynamics
                            8.3.3.2. Competitive scenario
                            8.3.3.3. Regulatory framework
                            8.3.3.4. Reimbursement scenario
                            8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
                        8.3.4. Mexico
                            8.3.4.1. Key country dynamics
                            8.3.4.2. Competitive scenario
                            8.3.4.3. Regulatory framework
                            8.3.4.4. Reimbursement scenario
                            8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
                    8.4. Europe
                        8.4.1. UK
                            8.4.1.1. Key country dynamics
                            8.4.1.2. Competitive scenario
                            8.4.1.3. Regulatory framework
                            8.4.1.4. Reimbursement scenario
                            8.4.1.5. UK market estimates and forecasts, 2021 - 2033
                        8.4.2. Germany
                            8.4.2.1. Key country dynamics
                            8.4.2.2. Competitive scenario
                            8.4.2.3. Regulatory framework
                            8.4.2.4. Reimbursement scenario
                            8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
                        8.4.3. France
                            8.4.3.1. Key country dynamics
                            8.4.3.2. Competitive scenario
                            8.4.3.3. Regulatory framework
                            8.4.3.4. Reimbursement scenario
                            8.4.3.5. France market estimates and forecasts, 2021 - 2033
                        8.4.4. Italy
                            8.4.4.1. Key country dynamics
                            8.4.4.2. Competitive scenario
                            8.4.4.3. Regulatory framework
                            8.4.4.4. Reimbursement scenario
                            8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
                        8.4.5. Spain
                            8.4.5.1. Key country dynamics
                            8.4.5.2. Competitive scenario
                            8.4.5.3. Regulatory framework
                            8.4.5.4. Reimbursement scenario
                            8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
                        8.4.6. Denmark
                            8.4.6.1. Key country dynamics
                            8.4.6.2. Competitive scenario
                            8.4.6.3. Regulatory framework
                            8.4.6.4. Reimbursement scenario
                            8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
                        8.4.7. Sweden
                            8.4.7.1. Key country dynamics
                            8.4.7.2. Competitive scenario
                            8.4.7.3. Regulatory framework
                            8.4.7.4. Reimbursement scenario
                            8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
                        8.4.8. Norway
                            8.4.8.1. Key country dynamics
                            8.4.8.2. Competitive scenario
                            8.4.8.3. Regulatory framework
                            8.4.8.4. Reimbursement scenario
                            8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
                    8.5. Asia Pacific
                        8.5.1. Japan
                            8.5.1.1. Key country dynamics
                            8.5.1.2. Competitive scenario
                            8.5.1.3. Regulatory framework
                            8.5.1.4. Reimbursement scenario
                            8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
                        8.5.2. India
                            8.5.2.1. Key country dynamics
                            8.5.2.2. Competitive scenario
                            8.5.2.3. Regulatory framework
                            8.5.2.4. Reimbursement scenario
                            8.5.2.5. India market estimates and forecasts, 2021 - 2033
                        8.5.3. China
                            8.5.3.1. Key country dynamics
                            8.5.3.2. Competitive scenario
                            8.5.3.3. Regulatory framework
                            8.5.3.4. Reimbursement scenario
                            8.5.3.5. China market estimates and forecasts, 2021 - 2033
                        8.5.4. South Korea
                            8.5.4.1. Key country dynamics
                            8.5.4.2. Competitive scenario
                            8.5.4.3. Regulatory framework
                            8.5.4.4. Reimbursement scenario
                            8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
                        8.5.5. Australia
                            8.5.5.1. Key country dynamics
                            8.5.5.2. Competitive scenario
                            8.5.5.3. Regulatory framework
                            8.5.5.4. Reimbursement scenario
                            8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
                        8.5.6. Thailand
                            8.5.6.1. Key country dynamics
                            8.5.6.2. Competitive scenario
                            8.5.6.3. Regulatory framework
                            8.5.6.4. Reimbursement scenario
                            8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
                    8.6. Latin America
                        8.6.1. Brazil
                            8.6.1.1. Key country dynamics
                            8.6.1.2. Competitive scenario
                            8.6.1.3. Regulatory framework
                            8.6.1.4. Reimbursement scenario
                            8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
                        8.6.2. Argentina
                            8.6.2.1. Key country dynamics
                            8.6.2.2. Competitive scenario
                            8.6.2.3. Regulatory framework
                            8.6.2.4. Reimbursement scenario
                            8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
                    8.7. MEA
                        8.7.1. South Africa
                            8.7.1.1. Key country dynamics
                            8.7.1.2. Competitive scenario
                            8.7.1.3. Regulatory framework
                            8.7.1.4. Reimbursement scenario
                            8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
                        8.7.2. Saudi Arabia
                            8.7.2.1. Key country dynamics
                            8.7.2.2. Competitive scenario
                            8.7.2.3. Regulatory framework
                            8.7.2.4. Reimbursement scenario
                            8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
                        8.7.3. UAE
                            8.7.3.1. Key country dynamics
                            8.7.3.2. Competitive scenario
                            8.7.3.3. Regulatory framework
                            8.7.3.4. Reimbursement scenario
                            8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
                        8.7.4. Kuwait
                            8.7.4.1. Key country dynamics
                            8.7.4.2. Competitive scenario
                            8.7.4.3. Regulatory framework
                            8.7.4.4. Reimbursement scenario
                            8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
Chapter 9. Competitive Landscape
                    9.1. Recent Developments & Impact Analysis, By Key Market Participants
                    9.2. Company/Competition Categorization
                        9.2.1. Innovators
                    9.3. Vendor Landscape
                        9.3.1. List of key distributors and channel partners
                        9.3.2. Key customers
                        9.3.3. Global Key company market share analysis, 2025
                        9.3.4. Cardinal Health
                            9.3.4.1. Company overview
                            9.3.4.2. Financial performance
                            9.3.4.3. Product benchmarking
                            9.3.4.4. Strategic initiatives
                        9.3.5. Curium Pharma
                            9.3.5.1. Company overview
                            9.3.5.2. Financial performance
                            9.3.5.3. Product benchmarking
                            9.3.5.4. Strategic initiatives
                        9.3.6. Jubilant Pharmova
                            9.3.6.1. Company overview
                            9.3.6.2. Financial performance
                            9.3.6.3. Product benchmarking
                            9.3.6.4. Strategic initiatives
                        9.3.7. Guerbet
                            9.3.7.1. Company overview
                            9.3.7.2. Financial performance
                            9.3.7.3. Product benchmarking
                            9.3.7.4. Strategic initiatives
                        9.3.8. Diagnostic Green
                            9.3.8.1. Company overview
                            9.3.8.2. Financial performance
                            9.3.8.3. Product benchmarking
                            9.3.8.4. Strategic initiatives
                        9.3.9. Sun Pharmaceutical Industries, Inc.
                            9.3.9.1. Company overview
                            9.3.9.2. Financial performance
                            9.3.9.3. Product benchmarking
                            9.3.9.4. Strategic initiatives
                        9.3.10. GE HealthCare
                            9.3.10.1. Company overview
                            9.3.10.2. Financial performance
                            9.3.10.3. Product benchmarking
                            9.3.10.4. Strategic initiatives
                        9.3.11. VIATRIS (Mylan Inc.)
                            9.3.11.1. Company overview
                            9.3.11.2. Financial performance
                            9.3.11.3. Product benchmarking
                            9.3.11.4. Strategic initiatives
                        9.3.12. Macsen Labs
                            9.3.12.1. Company overview
                            9.3.12.2. Financial performance
                            9.3.12.3. Product benchmarking
                            9.3.12.4. Strategic initiatives
                        9.3.13. POLATOM
                            9.3.13.1. Company overview
                            9.3.13.2. Financial performance
                            9.3.13.3. Product benchmarking
                            9.3.13.4. Strategic initiatives
                        9.3.14. Hologic Inc.
                            9.3.14.1. Company overview
                            9.3.14.2. Financial performance
                            9.3.14.3. Product benchmarking
                            9.3.14.4. Strategic initiatives
                    9.4. Heat Map Analysis/ Company Market Position Analysis
                    9.5. Estimated Company Market Share Analysis, 2025
                    9.6. List of Other Key Market Players

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America sentinel lymph node biopsy imaging agents market, by country, 2021 - 2033 (USD Million)
Table 4. North America sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 5. North America sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 6. North America sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 7. North America sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 8. U.S. sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 9. U.S. sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 10. U.S. sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 11. U.S. sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 12. Canada sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 13. Canada sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 14. Canada sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 15. Canada sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 16. Mexico sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 17. Mexico sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 18. Mexico sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 19. Mexico sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 20. Europe sentinel lymph node biopsy imaging agents market, by country, 2021 - 2033 (USD Million)
Table 21. Europe sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 22. Europe sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 23. Europe sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 24. Europe sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 25. UK sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 26. UK sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 27. UK sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 28. UK sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 29. Germany sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 30. Germany sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 31. Germany sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 32. Germany sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 33. France sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 34. France sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 35. France sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 36. France sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 37. Italy sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 38. Italy sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 39. Italy sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 40. Italy sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 41. Spain sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 42. Spain sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 43. Spain sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 44. Spain sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 45. Denmark sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 46. Denmark sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 47. Denmark sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 48. Denmark sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 49. Sweden sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 50. Sweden sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 51. Sweden sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 52. Sweden sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 53. Norway sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 54. Norway sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 55. Norway sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 56. Norway sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 57. Asia Pacific sentinel lymph node biopsy imaging agents market, by country, 2021 - 2033 (USD Million)
Table 58. Asia Pacific sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 59. Asia Pacific sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 60. Asia Pacific sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 61. Asia Pacific sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 62. China sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 63. China sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 64. China sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 65. China sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 66. Japan sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 67. Japan sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 68. Japan sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 69. Japan sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 70. India sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 71. India sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 72. India sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 73. India sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 74. South Korea sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 75. South Korea sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 76. South Korea sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 77. South Korea sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 78. Australia sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 79. Australia sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 80. Australia sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 81. Australia sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 82. Thailand sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 83. Thailand sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 84. Thailand sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 85. Thailand sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 86. Latin America sentinel lymph node biopsy imaging agents market, by country, 2021 - 2033 (USD Million)
Table 87. Latin America sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 88. Latin America sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 89. Latin America sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 90. Latin America sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 91. Brazil sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 92. Brazil sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 93. Brazil sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 94. Brazil sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 95. Argentina sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 96. Argentina sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 97. Argentina sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 98. Argentina sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 99. Middle East & Africa sentinel lymph node biopsy imaging agents market, by country, 2021 - 2033 (USD Million)
Table 100. Middle East & Africa sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 101. Middle East & Africa sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 102. Middle East & Africa sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 103. Middle East & Africa sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 104. South Africa sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 105. South Africa sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 106. South Africa sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 107. South Africa sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 108. Saudi Arabia sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 109. Saudi Arabia sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 110. Saudi Arabia sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 111. Saudi Arabia sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 112. UAE sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 113. UAE sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 114. UAE sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 115. UAE sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)
Table 116. Kuwait sentinel lymph node biopsy imaging agents market, by product, 2021 - 2033 (USD Million)
Table 117. Kuwait sentinel lymph node biopsy imaging agents market, by application, 2021 - 2033 (USD Million)
Table 118. Kuwait sentinel lymph node biopsy imaging agents market, by procedure, 2021 - 2033 (USD Million)
Table 119. Kuwait sentinel lymph node biopsy imaging agents market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Sentinel Lymph Node Biopsy Imaging Agents Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Sentinel Lymph Node Biopsy Imaging Agents Market: Product movement analysis
Fig. 15 Radioactive Tracers Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 16 Technetium-99m Sulfur Colloid Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 17 Technetium-99m Nanocolloid Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 18 Tilmanocept (Lymphoseek) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 19 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 20 Isosulfan Blue Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 21 Patent Blue V Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 22 Methylene Blue Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 23 Fluorescent Imaging Agents Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 24 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 25 Sentinel Lymph Node Biopsy Imaging Agents Market: Application Movement Analysis
Fig. 26 Breast Cancer Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 27 Melanoma Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 28 Head & Neck Cancer Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 29 Gynecological Cancers Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 30 Other Indications Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 31 Sentinel Lymph Node Biopsy Imaging Agents Market: Procedure Movement Analysis
Fig. 32 Open Surgery Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 33 Minimally Invasive Surgery Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 34 Sentinel Lymph Node Biopsy Imaging Agents Market: Application Movement Analysis
Fig. 35 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 36 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 37 Cancer Specialty Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 38 Regional Outlook, 2025 & 2033
Fig. 39 North America Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 40 U.S. Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 41 Canada Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 42 Mexico Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 43 Europe Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 44 Germany Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 45 UK Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 46 France Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 47 Italy Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 48 Spain Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 49 Denmark Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 50 Sweden Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 51 Norway Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 52 Asia Pacific Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 53 Japan Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 54 China Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 55 India Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 56 Australia Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 57 South Korea Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 58 Thailand Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 59 Latin America Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 60 Brazil Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 61 Argentina Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 62 Middle East and Africa Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 63 South Africa Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 64 Saudi Arabia Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 65 UAE Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)
Fig. 66 Kuwait Sentinel Lymph Node Biopsy Imaging Agents Market, 2021 - 2033 (USD Million)